Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with …
Latest in ACCESS Newswire
-
-
ACCESS Newswire
U.S. Polo Assn. Receives Multiple Global Honors Recognizing Excellence in Brand, Content, and Digital Growth
by gibouti.comWEST PALM BEACH, FL / ACCESS Newswire / November 20, 2025 / USPA Global …
-
ACCESS Newswire
Graid Technology Finalizes Intel VROC Licensing Agreement, Expanding Leadership in Enterprise Storage Solutions
by gibouti.comSUNNYVALE, CALIFORNIA / ACCESS Newswire / November 17, 2025 / Graid Technology today announced …
-
ACCESS Newswire
Graid Technology Finalizes Intel VROC Licensing Agreement, Expanding Leadership in Enterprise Storage Solutions
by gibouti.comSUNNYVALE, CALIFORNIA / ACCESS Newswire / November 17, 2025 / Graid Technology today announced …
-
Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE …
-
ACCESS Newswire
Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats
by gibouti.comLONDON, UK / ACCESS Newswire / November 14, 2025 / Two pioneering studies published …
-
ACCESS Newswire
Resin Solutions Announces Commencement of up to $100 Million Global HTPB Production Expansion Initiative
by gibouti.comEXTON, PA / ACCESS Newswire / November 11, 2025 / Resin Solutions, Exton, PA, …
-
This study of 1,000 Mexican adults reveals that over three-quarters have encountered a scam, …
-
SHARM EL-SHEIKH, EG / ACCESS Newswire / October 31, 2025 / Today, the Kingdom …
-
ACCESS Newswire
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
by gibouti.comStrategic Partnership to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad’s Genome Valley, Enhancing …